Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Heart Failure|December 22, 2019
Impact of aspirin on takotsubo syndrome: a propensity score-based analysis of the InterTAK RegistryFabrizio D'Ascenzo, Sebastiano Gili, Maurizio Bertaina, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 27, 2019
Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo RegistryKatharina J Ding, Victoria L Cammann, Konrad A Szawan, et al.
Journal of the American Heart Association|November 2, 2019
Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo RegistryStjepan Jurisic, Sebastiano Gili, Victoria L Cammann, et al.
European Heart Journal|August 30, 2025
Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery diseaseFlorian A Wenzl, Peizhi Wang, Florian Kahles, et al.
The Journal of Invasive Cardiology|June 23, 2020
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main StentingDaniela Trabattoni, Sebastiano Gili, Giovanni Teruzzi, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 1, 2022
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter RegistryMichele Millesimo, Edoardo Elia, Giorgio Marengo, et al.
European Heart Journal|June 3, 2020
Coexistence and outcome of coronary artery disease in Takotsubo syndromeL Christian Napp, Victoria L Cammann, Milosz Jaguszewski, et al.
BMC Cardiovascular Disorders|May 17, 2020
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)Mario Iannaccone, Umberto Barbero, Michele De Benedictis, et al.
European Heart Journal|August 31, 2024
Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS scoreFlorian A Wenzl, Peizhi Wang, Mattia Arrigo, et al.
European Heart Journal. Acute Cardiovascular Care|October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMIFederico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
Pageof 29